Rhino-orbital mucormycosis in a diabetes patient with renal impairment after amphotericin B deoxycholate: the role of amphotericin B lipid-complex treatment
DOI:
https://doi.org/10.12662/2317-3076jhbs.v9i1.3545.p%25p.2021Keywords:
Mucormycosis, Amphotericin B, Liposomal Formulation, Drug TherapyAbstract
Introduction: Mucormycosis is an infection caused by the ubiquitous saprophyte fungi with rapid and aggressive progression, especially in immunocompromised patients. Case report: A 57-year-old woman diagnosed with rhino-orbital mucormycosis presented with decreased renal function after treatment with amphotericin B deoxycholate which was discontinued. Renal function improved after amphotericin B lipid-complex, being also treated with itraconazole, and otorhinolaryngological surgery. Conclusion: The use of Amphotericin B deoxycholate may result in adverse effects. In this situation, Amphotericin B lipid formulation is usually the drug of choice.Downloads
Download data is not yet available.
Downloads
Published
2021-06-07
How to Cite
1.
Monteiro IGL, Farias LABG, de Araújo RMO, Pontes LB. Rhino-orbital mucormycosis in a diabetes patient with renal impairment after amphotericin B deoxycholate: the role of amphotericin B lipid-complex treatment. J Health Biol Sci. [Internet]. 2021 Jun. 7 [cited 2025 Jun. 27];9(1):1-4. Available from: https://unichristus.emnuvens.com.br/jhbs/article/view/3545
Issue
Section
Case Report
License
Copyright (c) 2021 Journal of Health & Biological Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.